These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5278156)

  • 1. Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines.
    Beare AS; Tyrrell DA; Hobson D; Howells CH; Pereira MS; Pollock TM; Tyler LE
    J Hyg (Lond); 1969 Mar; 67(1):1-11. PubMed ID: 5278156
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparison of subcutaneous, nasal, and combined influenza vaccination. I. Antigenicity.
    Gwaltney JM; Edmondson WP; Rothenberg R; White PW
    Am J Epidemiol; 1971 Jun; 93(6):472-9. PubMed ID: 5562719
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccination against Hong Kong influenza in Britain, 1968-9. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.
    Tyrrell DA; Buckland R; Rubenstein D; Sharpe DM
    J Hyg (Lond); 1970 Sep; 68(3):359-68. PubMed ID: 4917914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody responses and resistance to challenge in volunteers vaccinated with live attenuated, detergent split and oil adjuvant A2-Hong Kong-68 (H 3 N 2 ) influenza vaccines. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.
    Freestone DS; Hamilton-Smith S; Schild GC; Buckland R; Chinn S; Tyrrell DA
    J Hyg (Lond); 1972 Sep; 70(3):531-43. PubMed ID: 4506997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of subcutaneous, nasal, and combined influenza vaccination. II. Protection against natural challenge.
    Edmondson WP; Rothenberg R; White PW; Gwaltney JM
    Am J Epidemiol; 1971 Jun; 93(6):480-6. PubMed ID: 5562720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of monovalent Hong Kong influenza virus vaccine with vaccines containing only pre-1968 Asian strains in adult volunteers. A report to the Medical Research Council Committee on Influenza and other Respiratory Virus Vaccines.
    Hobson D; Baker FA; Chivers CP; Reed SE; Sharp D
    J Hyg (Lond); 1970 Sep; 68(3):369-78. PubMed ID: 4917915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutralization antibody response to A2 Hong Kong influenza vaccine and its duration in school age children.
    Hosai H; Omura S; Maeda A; Kunita N
    Biken J; 1970 Dec; 13(4):277-87. PubMed ID: 5510350
    [No Abstract]   [Full Text] [Related]  

  • 8. A field trial for evaluation of the prophylactic effect of influenza vaccine containing inactivated A2-Hong Kong and B influenza viruses.
    Sugiura A; Yanagawa H; Enomoto C; Ueda M; Tobita K
    J Infect Dis; 1970 Dec; 122(6):472-8. PubMed ID: 5496135
    [No Abstract]   [Full Text] [Related]  

  • 9. Immune response in volunteers to intranasal inoculation with freeze-dried influenza Q/Hong Kong/68 vaccine.
    Potter CW; Jennings R; McLaren C; Clarke A
    J Biol Stand; 1975; 3(1):41-50. PubMed ID: 1126961
    [No Abstract]   [Full Text] [Related]  

  • 10. [Course of antibodies in men after vaccination with the inactivated influenca vaccine Alorbat (author's transl)].
    Pressler K; Schenk KD
    Med Klin; 1978 Sep; 73(38):1321-6. PubMed ID: 703655
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 12. The sequential appearance of antibody and immunoglobins in nasal secretion after immunization of volunteers with live and inactivated influenza B virus vaccines.
    Downie JC
    J Hyg (Lond); 1973 Sep; 71(3):433-45. PubMed ID: 4518342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antiviral inhibitors and antibodies in the serum of subjects vaccinated against influenza].
    Kazakova VN; Kupriashina LM
    Vopr Virusol; 1971; 16(6):651-5. PubMed ID: 5141610
    [No Abstract]   [Full Text] [Related]  

  • 14. Correlated studies of a recombinant influenza-virus vaccine. IV. Protection against naturally occurring influenza in military trainees.
    Leibovitz A; Coultrip RL; Kilbourne ED; Legters LJ; Smith CD; Chin J; Schulman JL
    J Infect Dis; 1971 Nov; 124(5):481-7. PubMed ID: 5115671
    [No Abstract]   [Full Text] [Related]  

  • 15. Development of neutralizing, haemagglutination-inhibiting and strain-specific complement-fixing antibodies in guinea pigs given inactivated influenza vaccine.
    Závadová H; Vonka V
    Acta Virol; 1968 Mar; 12(2):151-6. PubMed ID: 4384403
    [No Abstract]   [Full Text] [Related]  

  • 16. Antibody response to influenza virus enzyme in man.
    Davenport FM; Minuse E; Hennessy AV
    Arch Environ Health; 1970 Sep; 21(3):307-11. PubMed ID: 5504431
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy of live and inactivated vaccines of Hong Kong influenza virus in an industrial community. A report to the Medical Research Council Committee on influenza and other respiratory virus vaccines.
    Hobson D; Baker FA; Curry RL; Beare AS; Massey PM
    J Hyg (Lond); 1973 Dec; 71(4):641-7. PubMed ID: 4588772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Sero-epidemiological investigations of the effectiveness of influenza vaccine with attenuated live viruses of types A2 and B].
    Ivan A; Vancea G; Zvorişteanu V; Oană C; Rusu F; Gherman A; Meleghi M
    Stud Cercet Inframicrobiol; 1968; 19(5):355-61. PubMed ID: 5716054
    [No Abstract]   [Full Text] [Related]  

  • 19. Further trials of live influenza vaccine.
    Andrews BE; Beare AS; McDonald JC; Zuckerman AJ; Tyrrell DA
    Br Med J; 1966 Mar; 1(5488):637-40. PubMed ID: 5908709
    [No Abstract]   [Full Text] [Related]  

  • 20. Single-dose monovalent A 2 -Hong Kong influenza vaccine. Efficacy 14 months after immunization.
    Foy HM; Cooney MK; McMahan R; Bor E; Grayston JT
    JAMA; 1971 Aug; 217(8):1067-71. PubMed ID: 5109428
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.